Advanced Micro Devices, Inc. AMD

Cara upgraded AMD to $400 over next 12 months

Holy smokes the MARKET IS ABOUT TO ???????????????

Sell American money destroyer before it destroy your portfolio

Back to 100$

$360+ this week I PROMISE

Big semiconductor crash ahead? Doesn’t look too beautiful

$AMD long and strong up $160 k . A little pull back no worries and normal. Bears are like blah Blah Blah . Bought at $109 up over 200 %

Pat Voss jacks it while looking at his own reflection in the mirror

NC’s rerating is a reversal back to their prior pt of $260 back in Feb

$TARA
As of April 2026, Protara Therapeutics (TARA) is a clinical-stage biotech stock with a "Strong Buy" consensus, trading around $5.13 with a 12-month average price target of $23.75. The company focuses on TARA-002 for cancer and rare diseases, recently reporting positive interim phase 2 data and a 68% complete response rate in NMIBC patients.
MSN
MSN
+2
Key Recent Developments & Stock News:
Analyst Outlook: Analysts have a "Strong Buy" consensus, with targets ranging from $21 to $27, indicating a high potential upside from current levels.
Clinical Progress: TARA-002, the company's lead program, showed 68% complete response rates at six months in patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC).